• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

1例新型冠状病毒肺炎相关的C-ANCA血管炎患者经利妥昔单抗治疗成功治愈。

A case of COVID-19-associated C-ANCA vasculitis, was successfully treated with rituximab therapy.

作者信息

Filoramo Michael, Contractor Renish, Chandramohan Deepak, Singh Prabhat, Jena Nihar, Simhadri Prathap Kumar

机构信息

FSU College of Medicine Daytona Beach Florida USA.

UAB School of Medicine Birmingham Alabama USA.

出版信息

Clin Case Rep. 2024 Aug 10;12(8):e9308. doi: 10.1002/ccr3.9308. eCollection 2024 Aug.

DOI:10.1002/ccr3.9308
PMID:39130811
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11316008/
Abstract

Both C-anti-neutrophil cytoplasmic antibody (ANCA) and P-ANCA vasculitis were reported to be associated with COVID-19 infection. The ideal management of COVID-19-associated ANCA vasculitis is unclear, as the experiences were limited to case reports. We presented a case of COVID-19-associated C-ANCA vasculitis, successfully treated with steroids and rituximab therapy without any significant adverse reactions.

摘要

据报道，C 型抗中性粒细胞胞浆抗体（ANCA）血管炎和 P 型 ANCA 血管炎均与 COVID-19 感染有关。由于经验仅限于病例报告，COVID-19 相关 ANCA 血管炎的理想治疗方法尚不清楚。我们报告了一例 COVID-19 相关 C 型 ANCA 血管炎病例，该病例通过类固醇和利妥昔单抗治疗成功治愈，且未出现任何明显不良反应。

相似文献

1
A case of COVID-19-associated C-ANCA vasculitis, was successfully treated with rituximab therapy.1例新型冠状病毒肺炎相关的C-ANCA血管炎患者经利妥昔单抗治疗成功治愈。
Clin Case Rep. 2024 Aug 10;12(8):e9308. doi: 10.1002/ccr3.9308. eCollection 2024 Aug.
2
Otitis Media with ANCA-Associated Vasculitis Following COVID-19 mRNA Vaccination: A Case Report.COVID-19 mRNA 疫苗接种后伴抗中性粒细胞胞浆抗体相关性血管炎的中耳炎：病例报告。
Am J Case Rep. 2024 Sep 30;25:e945301. doi: 10.12659/AJCR.945301.
3
c-ANCA-associated vasculitis with predominant CNS demyelination after COVID-19.COVID-19 后以中枢神经系统脱髓鞘为主的 c-ANCA 相关性血管炎。
Arch Pediatr. 2023 Jan;30(1):74-76. doi: 10.1016/j.arcped.2022.11.017. Epub 2022 Nov 30.
4
Case report: de novo ANCA-associated vasculitis after kidney transplantation treated with rituximab and plasma exchange.病例报告：肾移植后新发抗中性粒细胞胞浆抗体相关性血管炎，采用利妥昔单抗和血浆置换治疗。
BMC Nephrol. 2018 Oct 19;19(1):270. doi: 10.1186/s12882-018-1086-z.
5
Obinutuzumab as treatment for ANCA-associated vasculitis.奥滨尤妥珠单抗用于治疗抗中性粒细胞胞浆抗体相关性血管炎。
Rheumatology (Oxford). 2022 Aug 30;61(9):3814-3817. doi: 10.1093/rheumatology/keab916.
6
Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Renal Vasculitis Following COVID-19 Vaccination: A Case Report and Literature Review.新型冠状病毒肺炎疫苗接种后抗中性粒细胞胞浆抗体（ANCA）相关性肾血管炎：一例报告及文献综述
Cureus. 2022 Oct 11;14(10):e30206. doi: 10.7759/cureus.30206. eCollection 2022 Oct.
7
The COVID-19 pandemic and ANCA-associated vasculitis - reports from the EUVAS meeting and EUVAS education forum.COVID-19 大流行与抗中性粒细胞胞浆抗体相关性血管炎——EUVAS 会议和 EUVAS 教育论坛的报告。
Autoimmun Rev. 2021 Dec;20(12):102986. doi: 10.1016/j.autrev.2021.102986. Epub 2021 Oct 28.
8
The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: A retrospective study.中性粒细胞与淋巴细胞比值作为抗中性粒细胞胞浆抗体相关性血管炎活动、严重感染和死亡的标志物：一项回顾性研究。
Nefrologia (Engl Ed). 2021 May-Jun;41(3):321-328. doi: 10.1016/j.nefroe.2021.07.005.
9
Overlapping systemic lupus erythematosus, seropositive erosive rheumatoid arthritis, and ANCA-associated vasculitis: A case report and literature review.重叠性系统性红斑狼疮、血清阳性侵蚀性类风湿关节炎和 ANCA 相关性血管炎：病例报告及文献复习。
Mod Rheumatol Case Rep. 2023 Dec 29;8(1):21-25. doi: 10.1093/mrcr/rxad056.
10
ANCA-associated vasculitis flare might be provoked by COVID-19 infection: a case report and a review of the literature.新冠病毒感染可能引发抗中性粒细胞胞浆抗体相关性血管炎发作：一例病例报告及文献综述
Clin Kidney J. 2022 Aug 23;15(11):1987-1995. doi: 10.1093/ckj/sfac186. eCollection 2022 Nov.

本文引用的文献

1
Autoimmune and Autoinflammatory Connective Tissue Disorders Following COVID-19.COVID-19 后自身免疫和自身炎症性结缔组织病。
JAMA Netw Open. 2023 Oct 2;6(10):e2336120. doi: 10.1001/jamanetworkopen.2023.36120.
2
Newly diagnosed ANCA-associated vasculitis after COVID-19 infection: a case report.COVID-19 感染后新发的抗中性粒细胞胞质抗体相关性血管炎：一例报告。
J Med Case Rep. 2023 Aug 26;17(1):366. doi: 10.1186/s13256-023-04081-y.
3
ANCA-associated vasculitis flare might be provoked by COVID-19 infection: a case report and a review of the literature.
新冠病毒感染可能引发抗中性粒细胞胞浆抗体相关性血管炎发作：一例病例报告及文献综述
Clin Kidney J. 2022 Aug 23;15(11):1987-1995. doi: 10.1093/ckj/sfac186. eCollection 2022 Nov.
4
COVID-19 and autoimmune diseases: is there a connection?新型冠状病毒肺炎与自身免疫性疾病：存在关联吗？
Curr Opin Allergy Clin Immunol. 2023 Apr 1;23(2):185-192. doi: 10.1097/ACI.0000000000000888. Epub 2023 Jan 11.
5
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.接种 COVID-19 疫苗后的自身免疫和自身炎症性疾病。新病例报告和最新文献回顾。
J Autoimmun. 2022 Oct;132:102898. doi: 10.1016/j.jaut.2022.102898. Epub 2022 Aug 24.
6
ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine.辉瑞-BioNTech COVID-19 疫苗接种后与抗中性粒细胞胞浆抗体相关的血管炎。
Am J Kidney Dis. 2021 Oct;78(4):611-613. doi: 10.1053/j.ajkd.2021.06.016. Epub 2021 Jul 17.
7
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.血浆置换联合糖皮质激素治疗重症 ANCA 相关性血管炎。
N Engl J Med. 2020 Feb 13;382(7):622-631. doi: 10.1056/NEJMoa1803537.
8
Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis.利妥昔单抗与硫唑嘌呤用于抗中性粒细胞胞浆抗体相关性血管炎的维持治疗。
N Engl J Med. 2014 Nov 6;371(19):1771-80. doi: 10.1056/NEJMoa1404231.
9
Rituximab versus cyclophosphamide for ANCA-associated vasculitis.利妥昔单抗与环磷酰胺治疗抗中性粒细胞胞质抗体相关性血管炎。
N Engl J Med. 2010 Jul 15;363(3):221-32. doi: 10.1056/NEJMoa0909905.
10
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.利妥昔单抗与环磷酰胺治疗抗中性粒细胞胞质抗体相关性肾血管炎。
N Engl J Med. 2010 Jul 15;363(3):211-20. doi: 10.1056/NEJMoa0909169.